Author

Alison Gomeiz

George Mason University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alemayehu Abebe GorfeiD· 1 shared Chris B. Marshall· 1 shared Frank McCormickiD· 1 shared Gamze BildikiD· 1 shared Hailing Yang· 1 shared John F. HancockiD· 1 shared Junchen LiuiD· 1 shared Mariaelena PieroboniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alemayehu Abebe GorfeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

DIRAS3 broadly suppresses signaling from diverse oncogenic KRAS hotspot variants through an inhibitory interface

Gamze Bildik, Hailing Yang, Weiqun Mao, Ritchel B. Gannaban, Vijay Kumar Bhardwaj, Md Nasir Uddin, S-Y Jung, Mariaelena Pierobon, Alison Gomeiz, Alemayehu Abebe Gorfe, John F. Hancock, Chris B. Marshall, Frank McCormick, Steven W. Millward, Junchen Liu, , Zhen Lu

This study identifies DIRAS3 as a tumor suppressor that inhibits diverse oncogenic KRAS variants through a specific inhibitory interface, with a mimetic showing broad suppression of KRAS-driven signaling.

bioRxiv · Oct 22, 2026 · PreprintCancer Biology